Sanofi says U.S. regulators reject MS treatment Lemtrada
December 30, 2013 at 01:16 AM EST
PARIS, Dec 30 (Reuters) - Sanofi said its Lemtrada multiple sclerosis treatment failed to win approval from U.S. regulators to launch in the world's biggest drug market.
